Stephen L. Silvestro - Feb 15, 2024 Form 4/A Insider Report for OptimizeRx Corp (OPRX)

Role
Chief Commercial Officer
Signature
/s/ Marion Odence-Ford, by Power of Attorney
Stock symbol
OPRX
Transactions as of
Feb 15, 2024
Transactions value $
$0
Form type
4/A
Date filed
5/6/2024, 09:32 PM
Date Of Original Report
Apr 24, 2024
Previous filing
Feb 21, 2024
Next filing
May 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPRX Common Stock Award $0 +7.75K +84.64% $0.00 16.9K Feb 15, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 as originally filed reported in Table 1 a grant of Common Stock on March 15, 2024. However, this transaction occurred on February 15, 2024.
F2 Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant.
F3 A prior Form 4 filed by the Reporting Person failed to carry-forward previously owned shares, resulting in an understatement of the shares beneficially owned by the Reporting Person. The total amount beneficially owned has been adjusted to correct such inadvertent understatement.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.